ACHC, CTEV and CNL have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2025.
Investors need to pay close attention to ACHC stock based on the movements in the options market lately.
Investors need to pay close attention to ACHC stock based on the movements in the options market lately.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q1 2025 Results Conference Call May 13, 2025 8:30 AM ET Company Participants Brian Farley - EVP and General Counsel Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Brian Tanquilut - Jefferies Whit Mayo - Leerink Partners John Ransom - Raymond James Pito Chickering - Deutsche Bank Matthew Gillmor - KeyBanc Capital Markets Andrew Mok - Barclays Joanna Gajuk - Bank of America Operator Good day, and welcome to Acadia Healthcare's First Quarter of 2025 Earnings Call.
ACHC continues to witness growth in patient days. It authorizes a share repurchase program of almost $300 million.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.84 per share a year ago.
ACHC's first-quarter results are likely to reflect benefits from growing revenue per patient day.
ACHC, BLKB and CABO have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2025.
ASX, ACHC and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on March 27, 2025.
ASX, ACHC and GOLD have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2025.
ASTS, ACHC and ASX have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2025.
AMCX, ACHC and ADV have been added to the Zacks Rank #5 (Strong Sell) List on March 19, 2025.